SLC7A11 and Hepatic fibrosis: TRIM26 can inhibit liver fibrosis by mediating the ubiquitination of SLC7A11 and promoting the ferroptosis of hepatic stellate cells (HSCs), which can be used as a new therapeutic strategy for liver fibrosis (Zhu et al., 2021).